Skip to content

Mark Payson, M.D.

NPI 1629033634ActiveIndividual· Obstetrics & Gynecology, Reproductive Endocrinology· Bethesda, MD

Obstetrics & Gynecology, Reproductive Endocrinology (M.D.) in Bethesda, Maryland, licensed in MD, with an NPI issued in April 2006. Enrolled in Medicare as order and referring only - obstetrics/gynecology. Ferring Pharmaceuticals Inc. reported $354.16 in payments in 2025, mostly food and beverage.

Overview

NPI1629033634
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedApr 20, 2006
Last updated in NPPESJul 13, 2026

Specialties and licenses

TaxonomyCodeLicenseState
Obstetrics & Gynecology, Reproductive Endocrinology Primary207VE0102XD0056317MD

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Obstetrics/Gynecology (DC)

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$354.16 · 12 payments from 1 company
  • 2024$310.89 · 13 payments from 2 companies

Top paying companies in 2025

CompanyAmountPayments
Ferring Pharmaceuticals Inc.$354.1612

What the 2025 payments were for

  • Food and Beverage$354.16 · 12 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Obstetrics & Gynecology, Reproductive Endocrinology providers in Bethesda

All Obstetrics & Gynecology, Reproductive Endocrinology providers in Maryland